Allovectin-7 cancer gene therapy: Began Phase II trial in the U.S. and Canada in 100 patients

Vical Inc. (VICL), San Diego Product: Allovectin-7 cancer gene therapy, with a vector bearing a foreign tissue antigen, for direct injection into tumors in order to elicit an immune response against ...